. Author manuscript; available in PMC: 2013 Mar 5.

Published in final edited form as: Mol Pharm. 2011 Sep 21;9(3):374–381. doi: 10.1021/mp2003219

Table 1.

Molar relaxivity, half-life and rate of clearance measured for dendrimers and antibody-dendrimer agents.

Agent	r₁(mM^-1s^-1)	Half-life (min)	Rate of clearance (min^-1)
Magnevist™	4.1 ± 0.5	---	---
G4SS30	16.4 ± 1.2	12.5 ± 3	0.080 ± 0.025
G5SS58	27.3 ± 1.4	16.3 ± 4	0.061 ± 0.020
Ab-(G4S15)₄	6.7 ± 1.1	17.5 ± 3	0.057 ± 0.007
Ab-(G5S29)₄	9.1 ± 1.3	22.2 ± 7	0.045 ± 0.011